{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:51:45Z","timestamp":1787619105911,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005970","name":"Deutsche Stiftung f\u00fcr Herzforschung","doi-asserted-by":"crossref","award":["2021"],"award-info":[{"award-number":["2021"]}],"id":[{"id":"10.13039\/501100005970","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Deutsche Forschungs Gemeinschaft DFG","award":["SK46\/4-1"],"award-info":[{"award-number":["SK46\/4-1"]}]},{"name":"DFG","award":["SFB1192"],"award-info":[{"award-number":["SFB1192"]}]},{"name":"DFG","award":["TR124"],"award-info":[{"award-number":["TR124"]}]},{"name":"DFG","award":["210879364"],"award-info":[{"award-number":["210879364"]}]},{"name":"DFG","award":["C4"],"award-info":[{"award-number":["C4"]}]},{"name":"DFG","award":["C6"],"award-info":[{"award-number":["C6"]}]},{"DOI":"10.13039\/100012957","name":"Friedrich-Schiller-Universit\u00e4t Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atherosclerotic cardiovascular disease (ACVD) is a lipid-driven inflammatory disease and one of the leading causes of death worldwide. Lipid deposits in the arterial wall lead to the formation of plaques that involve lipid oxidation, cellular necrosis, and complement activation, resulting in inflammation and thrombosis. The present study found that homozygous deletion of the<jats:italic>CFHR1<\/jats:italic>gene, which encodes the plasma complement protein factor H-related protein 1 (FHR-1), was protective in two cohorts of patients with ACVD, suggesting that FHR-1 accelerates inflammation and exacerbates the disease. To test this hypothesis, FHR-1 was isolated from human plasma and was found to circulate on extracellular vesicles and to be deposited in atherosclerotic plaques. Surface-bound FHR-1 induced the expression of pro-inflammatory cytokines and tissue factor in both monocytes and neutrophils. Notably, plasma concentrations of FHR-1, but not of factor H, were significantly (p\u2009&lt;\u20090.001) elevated in patients with ACVD, and correlated with the expression of the inflammation markers C-reactive protein, apolipoprotein serum amyloid protein A, and neopterin. FHR-1 expression also significantly correlated with plasma concentrations of low-density lipoprotein (LDL) (p\u2009&lt;\u20090.0001) but not high-density lipoprotein (HDL). Taken together, these findings suggest that FHR-1 is associated with ACVD.<\/jats:p>","DOI":"10.1038\/s41598-021-02011-w","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:06:20Z","timestamp":1637233580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Sarah","family":"Irmscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svante L. H.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Gonzalez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Waldeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian J.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"von der Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"L\u00f6schmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Czamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Papac-Milicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Strau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal K.","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Wiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Skerka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2011_CR1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin, E. J. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics-2019 update: A report from the American Heart Association. Circulation 139, e56\u2013e528 (2019).","journal-title":"Circulation"},{"key":"2011_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e328364219d","volume":"20","author":"P Nagareddy","year":"2013","unstructured":"Nagareddy, P. & Smyth, S. S. Inflammation and thrombosis in cardiovascular disease. Curr. Opin. Hematol. 20, 457\u2013463 (2013).","journal-title":"Curr. Opin. Hematol."},{"key":"2011_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2362.2009.02216.x","volume":"40","author":"S Helske","year":"2010","unstructured":"Helske, S. et al. Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: A sign of ongoing inflammation. Eur. J. Clin. Investig. 40, 4\u201310 (2010).","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"2011_CR4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2015.05.038","volume":"241","author":"A Hovland","year":"2015","unstructured":"Hovland, A. et al. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis. Atherosclerosis 241(2), 480\u2013494 (2015).","journal-title":"Atherosclerosis"},{"key":"2011_CR5","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ajpath.2014.04.004","volume":"184","author":"S Vijayan","year":"2014","unstructured":"Vijayan, S. et al. High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques. Am. J. Pathol. 184, 2123\u20132133 (2014).","journal-title":"Am. J. Pathol."},{"key":"2011_CR6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1161\/CIRCULATIONAHA.106.619502","volume":"114","author":"A Schepers","year":"2006","unstructured":"Schepers, A. et al. Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice. Circulation 114, 2831\u20132838 (2006).","journal-title":"Circulation"},{"key":"2011_CR7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin, C. et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat. Med. 25, 496\u2013506 (2019).","journal-title":"Nat. Med."},{"key":"2011_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15290","author":"C Skerka","year":"2020","unstructured":"Skerka, C. et al. Factor H-related protein 1 (FHR-1): A complement regulatory protein and guardian of necrotic type surfaces. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.15290 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"2011_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12477","volume":"274","author":"N Medjeral-Thomas","year":"2016","unstructured":"Medjeral-Thomas, N. & Pickering, M. C. The complement factor H-related proteins. Immunol. Rev. 274, 191\u2013201 (2016).","journal-title":"Immunol. Rev."},{"key":"2011_CR10","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","volume":"114","author":"S Heinen","year":"2009","unstructured":"Heinen, S. et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114, 2439\u20132447 (2009).","journal-title":"Blood"},{"key":"2011_CR11","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","volume":"19","author":"LG Fritsche","year":"2010","unstructured":"Fritsche, L. G. et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 19, 4694\u20134704 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"2011_CR12","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","volume":"110","author":"EG de Jorge","year":"2013","unstructured":"de Jorge, E. G. et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. U.S.A. 110, 4685\u20134690 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2011_CR13","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1038\/s41467-019-10766-0","volume":"10","author":"S Irmscher","year":"2019","unstructured":"Irmscher, S. et al. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nat. Commun. 10, 2961 (2019).","journal-title":"Nat. Commun."},{"key":"2011_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 43, 321\u2013327 (2011).","journal-title":"Nat. Genet."},{"issue":"38","key":"2011_CR15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/07853890601097030","volume":"206","author":"GS Hageman","year":"2006","unstructured":"Hageman, G. S. et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications. Ann. Med. 206(38), 592\u2013604 (2006).","journal-title":"Ann. Med."},{"key":"2011_CR16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng1890","volume":"38","author":"AE Hughes","year":"2006","unstructured":"Hughes, A. E. et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 38, 1173\u20131177 (2006).","journal-title":"Nat. Genet."},{"key":"2011_CR17","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1167\/iovs.09-3975","volume":"50","author":"KE Schmid-Kubista","year":"2009","unstructured":"Schmid-Kubista, K. E. et al. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 50, 5070\u20135079 (2009).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"2011_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","volume":"46","author":"MA Dragon-Durey","year":"2009","unstructured":"Dragon-Durey, M. A. et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J. Med. Genet. 46, 447\u2013450 (2009).","journal-title":"J. Med. Genet."},{"key":"2011_CR19","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","volume":"3","author":"PF Zipfel","year":"2007","unstructured":"Zipfel, P. F. et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 3, e41. https:\/\/doi.org\/10.1371\/journal.pgen.0030041 (2007).","journal-title":"PLoS Genet."},{"key":"2011_CR20","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.1073\/pnas.1913970117","volume":"117","author":"L Alic","year":"2020","unstructured":"Alic, L. et al. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes. Proc. Natl. Acad. Sci. U.S.A. 117, 9942\u20139951 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2011_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","volume":"558","author":"X Que","year":"2018","unstructured":"Que, X. et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558, 301\u2013306 (2018).","journal-title":"Nature"},{"key":"2011_CR22","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","volume":"37","author":"A Janoudi","year":"2016","unstructured":"Janoudi, A., Shamoun, F. E., Kalavakunta, J. K. & Abela, G. S. Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque. Eur. Heart J. 37, 1959\u20131967 (2016).","journal-title":"Eur. Heart J."},{"key":"2011_CR23","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","volume":"192","author":"EO Samstad","year":"2014","unstructured":"Samstad, E. O. et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. (Baltimore) 192, 2837\u20132845 (2014).","journal-title":"J. Immunol. (Baltimore)"},{"key":"2011_CR24","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1038\/s41586-018-0313-x","volume":"561","author":"X Que","year":"2018","unstructured":"Que, X. et al. Publisher Correction: Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolemia mice. Nature 561, E43 (2018).","journal-title":"Nature"},{"key":"2011_CR25","doi-asserted-by":"crossref","first-page":"613780","DOI":"10.3389\/fphar.2020.613780","volume":"11","author":"AV Poznyak","year":"2021","unstructured":"Poznyak, A. V. et al. Overview of OxLDL and its impact on cardiovascular health: Focus on atherosclerosis. Front. Pharmacol. 11, 613780 (2021).","journal-title":"Front. Pharmacol."},{"key":"2011_CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","volume":"19","author":"ES Reis","year":"2019","unstructured":"Reis, E. S., Mastellos, D. C., Hajishengallis, G. & Lambris, J. D. New insights into the immune functions of complement. Nat. Rev. Immunol. 19, 503\u2013516 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2011_CR27","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1074\/jbc.271.30.18054","volume":"271","author":"CT Park","year":"1996","unstructured":"Park, C. T. & Wright, S. D. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J. Biol. Chem. 271, 18054\u201318060 (1996).","journal-title":"J. Biol. Chem."},{"key":"2011_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","volume":"265","author":"CM Uhlar","year":"1999","unstructured":"Uhlar, C. M. & Whitehead, A. S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501\u2013523 (1999).","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"2011_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr, C., Widner, B., Wirleitner, B. & Fuchs, D. Neopterin as a marker for immune system activation. Curr. Drug Metab. 3(2), 175\u2013187 (2002).","journal-title":"Curr. Drug Metab."},{"key":"2011_CR30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/hc3801.095588","volume":"104","author":"AD Michelson","year":"2001","unstructured":"Michelson, A. D., Barnard, M. R., Krueger, L. A., Valerim, C. R. & Furman, M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104, 1533\u20131537 (2001).","journal-title":"Circulation"},{"key":"2011_CR31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","volume":"30","author":"AV Finn","year":"2010","unstructured":"Finn, A. V., Nakano, M., Narula, J., Kolodgie, F. D. & Virmani, R. Concept of vulnerable\/unstable plaque. Arterioscler. Thromb. Vasc. Biol. 30, 1282\u20131292 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2011_CR32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins, P. D. & Morelli, A. E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14, 195\u2013208 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2011_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3402\/jev.v3.23262","volume":"8","author":"Y Yuana","year":"2014","unstructured":"Yuana, Y., Levels, J., Grootemaat, A., Sturk, A. & Nieuwland, R. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J. Extracell. Vesicles 8, 3. https:\/\/doi.org\/10.3402\/jev.v3.23262 (2014).","journal-title":"J. Extracell. Vesicles"},{"key":"2011_CR34","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.300741","volume":"33","author":"J Wagner","year":"2013","unstructured":"Wagner, J. et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 33, 1392\u20131400 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2011_CR35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCRESAHA.117.311767","volume":"121","author":"JB Simonsen","year":"2017","unstructured":"Simonsen, J. B. What are we looking at? Extracellular vesicles, lipoproteins, or both?. Circ. Res. 121, 920\u2013922 (2017).","journal-title":"Circ. Res."},{"key":"2011_CR36","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1038\/s41467-020-16241-5","volume":"11","author":"LD Halder","year":"2020","unstructured":"Halder, L. D. et al. Immune modulation by complement receptor 3-dependent human monocyte TGF-\u03b21-transporting vesicles. Nat. Commun. 11, 2331. https:\/\/doi.org\/10.1038\/s41467-020-16241-5 (2020).","journal-title":"Nat. Commun."},{"key":"2011_CR37","doi-asserted-by":"publisher","first-page":"e12031","DOI":"10.1002\/jev2.1203136","volume":"10","author":"X Mao","year":"2020","unstructured":"Mao, X. et al. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells. J. Extracell. Vesicles 10, e12031. https:\/\/doi.org\/10.1002\/jev2.1203136 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"2011_CR38","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1002\/asia.202000873","volume":"15","author":"Z Jiang","year":"2020","unstructured":"Jiang, Z., Liu, G. & Li, J. Recent progress on the isolation and detection methods of exosomes. Chem. Asian J. 15, 3973\u20133982 (2020).","journal-title":"Chem. Asian J."},{"key":"2011_CR39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","volume":"92","author":"NR Medjeral-Thomas","year":"2017","unstructured":"Medjeral-Thomas, N. R. et al. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy. Kidney Int. 92, 942\u2013952 (2017).","journal-title":"Kidney Int."},{"key":"2011_CR40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","volume":"92","author":"A Tortajada","year":"2017","unstructured":"Tortajada, A. et al. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy. Kidney Int. 92, 953\u2013963 (2017).","journal-title":"Kidney Int."},{"key":"2011_CR41","doi-asserted-by":"publisher","first-page":"e23297","DOI":"10.1002\/jcla.23297","volume":"34","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Screening and identification of serum biomarkers of osteoarticular tuberculosis based on mass spectrometry. J. Cin. Lab. Anal. 34, e23297. https:\/\/doi.org\/10.1002\/jcla.23297 (2020).","journal-title":"J. Cin. Lab. Anal."},{"key":"2011_CR42","first-page":"3642","volume":"20","author":"G Wu","year":"2019","unstructured":"Wu, G. et al. CFHR1 is a potentially downregulated gene in lung adenocarcinoma. Mol. Med. Rep. 20, 3642\u20133648 (2019).","journal-title":"Mol. Med. Rep."},{"key":"2011_CR43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fphar.2019.00666","volume":"10","author":"MC Flynn","year":"2019","unstructured":"Flynn, M. C., Pernes, G., Lee, M. K. S., Nagareddy, P. R. & Murphy, A. J. Monocytes, macrophages, and metabolic disease in atherosclerosis. Front. Pharmacol. 10, 666 (2019).","journal-title":"Front. Pharmacol."},{"key":"2011_CR44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4049\/jimmunol.1900503","volume":"203","author":"CS Gravastrand","year":"2019","unstructured":"Gravastrand, C. S. et al. Cholesterol crystals induce coagulation activation through complement-dependent expression of monocytic tissue factor. J. Immunol. 203, 853\u2013863 (2019).","journal-title":"J. Immunol."},{"key":"2011_CR45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurheartj\/ehv718","volume":"37","author":"AJ Murphy","year":"2016","unstructured":"Murphy, A. J. & Tall, A. R. Disordered hematopoiesis and athero-thrombosis. Eur. Heart J. 37, 1113\u20131121 (2016).","journal-title":"Eur. Heart J."},{"key":"2011_CR46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.21037\/cdt.2016.06.01","volume":"6","author":"F Otsuka","year":"2016","unstructured":"Otsuka, F., Yasuda, S., Noguchi, T. & Ishibashi-Ueda, H. Pathology of coronary atherosclerosis and thrombosis. Cardiovasc. Diagn. Ther. 6, 396\u2013408 (2016).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"2011_CR47","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.0604260103","volume":"103","author":"FK Swirski","year":"2006","unstructured":"Swirski, F. K. et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U.S.A. 103, 10340\u201310345 (2006).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2011_CR48","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","volume":"394","author":"L Boring","year":"1998","unstructured":"Boring, L., Gosling, J., Cleary, M. & Charo, I. F. Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894\u2013897 (1998).","journal-title":"Nature"},{"key":"2011_CR49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI5624","volume":"103","author":"J Gosling","year":"1999","unstructured":"Gosling, J. et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Investig. 103, 773\u2013778 (1999).","journal-title":"J. Clin. Investig."},{"key":"2011_CR50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Investig. 117, 185\u2013194 (2007).","journal-title":"J. Clin. Investig."},{"key":"2011_CR51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","volume":"17","author":"PR Nagareddy","year":"2013","unstructured":"Nagareddy, P. R. et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metabol. 17, 695\u2013708 (2013).","journal-title":"Cell Metabol."},{"key":"2011_CR52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Anti-inflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20132113 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2011_CR53","first-page":"1826","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu, J. et al. NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin. Mol. Med. Rep. 20, 1826\u20131836 (2019).","journal-title":"Mol. Med. Rep."},{"key":"2011_CR54","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif, J.-C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497\u20132505 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2011_CR55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","volume":"117","author":"L Liberale","year":"2021","unstructured":"Liberale, L., Montecucco, F., Schwarz, L. & L\u00fcscher, T. F. Inflammation and cardiovascular diseases: Lessons from seminal clinical trials. Cardiovasc. Res. 117, 411\u2013422 (2021).","journal-title":"Cardiovasc. Res."},{"key":"2011_CR56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/oxfordjournals.aje.a117648","volume":"142","author":"JR Vingerling","year":"1995","unstructured":"Vingerling, J. R. et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol. 142, 404\u2013409 (1995).","journal-title":"Am. J. Epidemiol."},{"key":"2011_CR57","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2005.11.076","volume":"47","author":"I Kardys","year":"2006","unstructured":"Kardys, I. et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: The Rotterdam Study. J. Am. Coll. Cardiol. 47, 1568\u20131575 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2011_CR58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-467-4_2","volume":"412","author":"WM Nauseef","year":"2007","unstructured":"Nauseef, W. M. Isolation of human neutrophils from venous blood. Methods Mol. Biol. 412, 15\u201320 (2007).","journal-title":"Methods Mol. Biol."},{"key":"2011_CR59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.atherosclerosis.2018.06.877","volume":"275","author":"C Waldeyer","year":"2018","unstructured":"Waldeyer, C. et al. Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohort. Atherosclerosis 275, 256\u2013261 (2018).","journal-title":"Atherosclerosis"},{"key":"2011_CR60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1479-5876-9-91","volume":"9","author":"JC Mychaleckyj","year":"2011","unstructured":"Mychaleckyj, J. C. et al. Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage. J. Transl. Med. 9, 91 (2011).","journal-title":"J. Transl. Med."},{"key":"2011_CR61","first-page":"3","volume":"8","author":"AN B\u00f6ing","year":"2014","unstructured":"B\u00f6ing, A. N. et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J. Extracell. Vesicles 8, 3 (2014).","journal-title":"J. Extracell. Vesicles"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02011-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02011-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02011-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T15:09:57Z","timestamp":1726153797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02011-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02011-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22511"}}